Grifols Biopharma

Join us at the Grifols Tea Symposium during the Asian Pacific Association for the Study of the Liver (APASL) Single Topic Conference 2026. Our session, Balancing Clinical Outcomes and Economics: Cost-Effectiveness of Albumin in Cirrhosis for Acute and Long-Term Management, will explore cirrhosis management from a healthcare economic perspective. The session will be chaired by Dr. Therese Capalongan Macatula and presented by Dr. Irsan Hasan, a recognized leader in hepatology with extensive expertise in cirrhosis and its complications. We look forward to connecting with you in Singapore. #APASLSTC2026 #Hepatology #Cirrhosis #LiverDisease  

The 12th Congress of the European Academy of Neurology (EAN congress 2026) will bring together neurologists, scientists, educators, and healthcare professionals worldwide in Geneva to share scientific advances and promote improvements in the care of patients with neurological diseases. The EAN 2026 Grifols satellite symposium will provide practical and up-to-date insights into chronic inflammatory demyelinating polyneuropathy (CIDP) focusing on disease mechanisms, accurate diagnosis using current criteria and decision support tools and strategies to optimize patient management. Featuring: Dr. Luis Querol (Barcelona) Dr. Kathrin Doppler (Würzburg) Dr. Robert Hadden (London) Save it to your calendar👉https://lnkd.in/eFceSaYr #EAN2026 #Neurology #CIDP #MedicalEducation #Grifols

 Come visit us at #ANZAN2026, from the 23rd to the 26th of June. #ANZAN is the Annual Scientific Meeting of the Australian and New Zealand Association of Neurologists. We look forward to seeing you there.

Join us online on June 18th for an upcoming scientific webinar exploring the evolving role of long-term albumin therapy in decompensated cirrhosis, presented by Dr. Salvatore Piano. To make participation easier across different schedules, the webinar will be offered in two sessions. Discover the agenda and register below:  🕙 Morning session: 10:00–10:45 AM CEST - https://lnkd.in/eFWpKiCc 🕒 Afternoon session: 15:00–15:45 PM CEST - https://lnkd.in/eVrChfYq #Hepatology #Cirrhosis #AlbuminTherapy #ClinicalPractice #Webinar

Which topics in immune thrombocytopenia (ITP) will be discussed in our Update‑in‑Hematology at EHA2026 Congress?  Discover the agenda and key topics of our scientific session 👉  https://lnkd.in/d49TYtZR #EHA2026 #ITP #Hematology 

EASL Congress 2026 is coming to Barcelona, bringing together the global hepatology community—and we will be there. Join our session: “Long-term albumin as a disease-modifying therapy in decompensated cirrhosis: integrating evidence into practice” 👉 https://lnkd.in/dz78q3R6 We will explore how clinical evidence can be translated into everyday practice and what it means for patient management. Let’s connect at #EASLCongress.

Meet us at the EHA2026 Congress and join our Update-in-Hematology to explore current insights into immune thrombocytopenia (ITP), from science to real‑world clinical experience👉 https://lnkd.in/dct7yyah    #EHA2026 #ITP #Hematology 

We are proud to announce that an article on the use of fibrinogen concentrate in patients with congenital fibrinogen deficiency has been published in Thrombosis Research👉https://lnkd.in/dSED3pnY #innovation #clinicalresearch 

We are proud to announce that study results of a clinical trial in patients with Primary Immunodeficiency have been published in the Journal of Clinical Immunology. 👉 https://lnkd.in/ekS5MMtw #innovation #clinicalresearch